Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Farmers Insurance
Moodys
Boehringer Ingelheim
AstraZeneca
US Army
Medtronic
Julphar

Generated: November 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020413

« Back to Dashboard

NDA 020413 describes ZERIT, which is a drug marketed by Bristol Myers Squibb and is included in three NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the ZERIT profile page.

The generic ingredient in ZERIT is stavudine. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the stavudine profile page.
Summary for 020413
Tradename:ZERIT
Applicant:Bristol Myers Squibb
Ingredient:stavudine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020413
Medical Subject Heading (MeSH) Categories for 020413
Suppliers and Packaging for NDA: 020413
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZERIT stavudine FOR SOLUTION;ORAL 020413 NDA E.R. Squibb & Sons, L.L.C. 0003-1968 0003-1968-01 200 mL in 1 BOTTLE (0003-1968-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrength1MG/ML
Approval Date:Sep 6, 1996TE:AARLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
Citi
Cipla
Covington
Express Scripts
Chubb
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.